Pretreatment of ghrelin protects H9c2 cells against hypoxia/reoxygenation-induced cell death via PI3K/AKT and AMPK pathways

References

• Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–660.
   PubMed Web of Science ®Google Scholar
• Lilleness BM, Frishman WH. Ghrelin and the cardiovascular system. Cardiol Rev. 2016;24:288–297.
   PubMed Web of Science ®Google Scholar
• Gurgul E, Kasprzak A, Blaszczyk A, et al. Ghrelin and obestatin in thyroid gland – immunohistochemical expression in nodular goiter, papillary and medullary cancer. Folia Histochem Cytobiol. 2015;53:19–25.
   PubMed Web of Science ®Google Scholar
• Tian X, Liu Z, Yu T, et al. Ghrelin ameliorates acute lung injury induced by oleic acid via inhibition of endoplasmic reticulum stress. Life Sci. 2018;196:1–8.
   PubMed Web of Science ®Google Scholar
• Beiras-Fernandez A, Kreth S, Weis F, et al. Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure. Peptides. 2010;31:2222–2228.
   PubMed Web of Science ®Google Scholar
• Gortan Cappellari G, Barazzoni R. Ghrelin forms in the modulation of energy balance and metabolism. Eating and weight disorders. EWD. 2018. doi:10.1007/s40519-018-0599-6.
   Google Scholar
• Horvath TL, Abizaid A, Dietrich MO, et al. Ghrelin-immunopositive hypothalamic neurons tie the circadian clock and visual system to the lateral hypothalamic arousal center. Mol Metab. 2012;1:79–85.
   PubMed Web of Science ®Google Scholar
• Kishimoto I, Tokudome T, Hosoda H, et al. Ghrelin and cardiovascular diseases. J Cardiol. 2012;59:8–13.
   PubMed Web of Science ®Google Scholar
• Zhu J, Yao J, Huang R, et al. Ghrelin promotes human non-small cell lung cancer A549 cell proliferation through PI3K/Akt/mTOR/P70S6K and ERK signaling pathways. Biochem Biophys Res Commun. 2018;498:616–620.
   PubMed Web of Science ®Google Scholar
• Murphy G, Cross AJ, Dawsey SM, et al. Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study. Gut 2017;67(9):1646–1651.
   PubMed Web of Science ®Google Scholar
• Zhu CZ, Liu D, Kang WM, et al. Ghrelin and gastrointestinal stromal tumors. WJG. 2017;23:1758–1763.
   PubMed Web of Science ®Google Scholar
• Wang Q, Lin P, Li P, et al. Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway. Life Sci. 2017;186:50–58.
   PubMed Web of Science ®Google Scholar
• Nagaya N, Miyatake K, Uematsu M, et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab. 2001;86:5854–5859.
   PubMed Web of Science ®Google Scholar
• Zabarovskaja S, Freda P, Williams JJ, et al. Acylation of ghrelin is increased in heart failure and decreases post heart transplantation. SCJ. 2014;48:343–348.
   Google Scholar
• Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004;110:3674–3679.
   PubMed Web of Science ®Google Scholar
• Liao P, Yang D, Liu D, et al. GLP-1 and Ghrelin attenuate high glucose/high lipid-induced apoptosis and senescence of human microvascular endothelial cells. Cell Physiol Biochem. 2017;44:1842–1855.
   PubMedGoogle Scholar
• Tong XX, Wu D, Wang X, et al. Ghrelin protects against cobalt chloride-induced hypoxic injury in cardiac H9c2 cells by inhibiting oxidative stress and inducing autophagy. Peptides. 2012;38:217–227.
   PubMed Web of Science ®Google Scholar
• Wang X, Yang C, Liu X, et al. Ghrelin alleviates angiotensin II-induced H9c2 apoptosis: impact of the miR-208 family. Med Sci Monit. 2018;24:6707–6716.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Pathophysiology of myocardial infarction. Compr Physiol. 2015;5:1841–1875.
   PubMed Web of Science ®Google Scholar
• Shen H, Yao Z, Zhao W, et al. miR-21 enhances the protective effect of loperamide on rat cardiomyocytes against hypoxia/reoxygenation, reactive oxygen species production and apoptosis via regulating Akap8 and Bard1 expression. Exp Ther Med. 2019;17:1312–1320.
   PubMed Web of Science ®Google Scholar
• Mendes RT, Nguyen D, Stephens D, et al. Hypoxia-induced endothelial cell responses – possible roles during periodontal disease. 2018;4:241–248.
   Google Scholar
• Bhattacharya I, Dominguez AP, Dragert K, et al. Hypoxia potentiates tumor necrosis factor-alpha induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in white and brown adipocytes. Biochem Biophys Res Commun. 2015;461:287–292.
   PubMed Web of Science ®Google Scholar
• Carnieto A, Jr., Dourado PM, Luz PL, et al. Selective cyclooxygenase-2 inhibition protects against myocardial damage in experimental acute ischemia. Clinics (Sao Paulo, Brazil). 2009;64:245–252.
   PubMed Web of Science ®Google Scholar
• Eid RA, Alkhateeb MA, Al-Shraim M, et al. Ghrelin prevents cardiac cell apoptosis during cardiac remodelling post experimentally induced myocardial infarction in rats via activation of Raf-MEK1/2-ERK1/2 signalling. Arch Physiol Biochem. 2019; 125:93-103. doi:10.1080/13813455.2018.1437751.
   PubMed Web of Science ®Google Scholar
• Eid RA, Zaki MSA, Al-Shraim M, et al. Subacute ghrelin administration inhibits apoptosis and improves ultrastructural abnormalities in remote myocardium post-myocardial infarction. Biomed Pharmacother = Biomedecine & Pharmacotherapie. 2018;101:920–928.
   PubMed Web of Science ®Google Scholar
• Eid RA, Alkhateeb MA, Eleawa S, et al. Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2/STAT3 signaling. Basic Res Cardiol. 2018;113:13.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Yasuda S, Miyazaki S, et al. Decreased serum ghrelin levels in patients with acute myocardial infarction. Tohoku J Exp Med. 2013;231:235–242.
   PubMed Web of Science ®Google Scholar
• Sun N, Wang H, Wang L. Protective effects of ghrelin against oxidative stress, inducible nitric oxide synthase and inflammation in a mouse model of myocardial ischemia/reperfusion injury via the HMGB1 and TLR4/NF-kappaB pathway. Mol Med Rep. 2016;14:2764–2770.
   PubMed Web of Science ®Google Scholar
• Wang L, Lu Y, Liu X, et al. Ghrelin protected neonatal rat cardiomyocyte against hypoxia/reoxygenation injury by inhibiting apoptosis through Akt-mTOR signal. Mol Biol Rep. 2017;44:219–226.
   PubMed Web of Science ®Google Scholar
• Yang D, Liu Z, Zhang H, et al. Ghrelin protects human pulmonary artery endothelial cells against hypoxia-induced injury via PI3-kinase/Akt. Peptides. 2013;42:112–117.
   PubMed Web of Science ®Google Scholar
• Zhang G, Yin X, Qi Y, et al. Ghrelin and cardiovascular diseases. CCR. 2010;6:62–70.
   Google Scholar
• Ye N, Wang L, Dou Z, et al. Ghrelin accelerates the cartilagic differentiation of rabbit mesenchymal stem cells through the ERK1/2 pathway. Cytotechnology. 2018;70:415–421.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang S, Pan Z, et al. AMPK/NF-kappaB signaling pathway regulated by ghrelin participates in the regulation of HUVEC and THP1 Inflammation. Mol Cell Biochem. 2018;437:45–53.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang XL, Chen HL, et al. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Biochem Pharmacol. 2014;88:334–350.
   PubMed Web of Science ®Google Scholar
• Tang L, Mo Y, Li Y, et al. Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway. Biochem Biophys Res Commun. 2017;486:774–780.
   PubMed Web of Science ®Google Scholar
• Sulaiman D, Li J, Devarajan A, et al. Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3beta RISK pathway. J Mol Cell Cardiol. 2019;129:154–164.
   PubMed Web of Science ®Google Scholar
• Qi D, Young LH. AMPK: energy sensor and survival mechanism in the ischemic heart. TEM. 2015;26:422–429.
   PubMed Web of Science ®Google Scholar
• Mittal D, Taliyan R, Sharma PL, et al. Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart. Indian J Pharmacol. 2016;48:59–63.
   PubMed Web of Science ®Google Scholar
• Oronsky B, Ao-Ieong ES, Yalcin O, et al. Cardioprotective effect of phase 3 clinical anticancer agent, RRx-001, in doxorubicin-induced acute cardiotoxicity in mice. Mol Pharm. 2019. doi:10.1021/acs.molpharmaceut.9b00150.
   PubMedGoogle Scholar
• Angeloni C, Teti G, Barbalace MC, et al. 17Beta-estradiol enhances sulforaphane cardioprotection against oxidative stress. J Nutr Biochem. 2017;42:26–36.
   PubMed Web of Science ®Google Scholar
• Gu Y, Liang Z, Wang H, et al. Tanshinone IIA protects H9c2 cells from oxidative stress-induced cell death via microRNA-133 upregulation and Akt activation. Exp Ther Med. 2016;12:1147–1152.
   PubMed Web of Science ®Google Scholar